Stay updated on B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added new study locations (California and several states) and updated to revision v3.3.3, replacing the previous location groupings.
    Difference
    0.7%
    Check dated 2025-12-22T01:50:01.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    36 days ago
    Change Detected
    Summary
    The page shows a revision update from v3.3.1 to v3.3.2, indicating a minor version change. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-30T16:11:36.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Minor UI change updating the page revision from v3.2.0 to v3.3.1 at the top of the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-23T14:46:22.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Funding/operating status banner has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-16T14:16:30.000Z thumbnail image
  8. Check
    65 days ago
    Change Detected
    Summary
    No significant changes detected between the two screenshots; the page content appears unchanged.
    Difference
    0.3%
    Check dated 2025-11-02T00:51:33.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a new government-operating status notice and funding caveat; removes v3.1.0. This introduces current-operational caveats and directs users to status pages.
    Difference
    3%
    Check dated 2025-10-04T12:31:24.000Z thumbnail image

Stay in the know with updates to B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the B-701 & Pembrolizumab in Urothelial Cancer Clinical Trial page.